Enhancing myocardial injury recovery: Nrf2 activation by sulforaphane regulates ferroptosis and oxidative stress in takotsubo-like models
International Immunopharmacology · 2025-12 · 167 · 115659
DOI: 10.1016/j.intimp.2025.115659 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025-12. Verfasst von Yuxi Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhuhai, Guangdong 519000, China; Department of Geriatri…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Isothiocyanates, Sulfoxides, Myocytes, Cardiac. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundo para o Desenvolvimento das Ciências e da Tecnologia.
Abstract (Originalsprache)
Takotsubo syndrome (TTS), once considered benign, can cause life-threatening myocardial injury. Although oxidative stress and ferroptosis are implicated in its pathogenesis, targeted therapies are not available for TTS. We demonstrate that sulforaphane (SFN), a natural Nrf2 activator, mitigates TTS-related injury in isoproterenol-induced rat models and AC16 cardiomyocytes. Isoproterenol induced ferroptosis and oxidative stress by impairing Nrf2 signaling. SFN treatment restored myocardial structure and function while enhancing antioxidant capacity, reducing mitochondrial damage, and suppressing ferroptosis markers. Additionally, similar to Fer-1 (a ferroptosis inhibitor), SFN reduced intracellular ferrous levels but uniquely activated Nrf2-driven endogenous defenses. Notably, Nrf2 inhibition abrogated the benefits of SFN in both in vitro and in vivo experiments. These findings highlight SFN as a dual-action therapeutic for TTS, simultaneously targeting oxidative stress and ferroptosis via Nrf2 activation. The therapeutic efficacy of SFN, combined with endogenous pathway modulation, underscores its translational potential for improving TTS outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhuhai, Guangdong 519000, China; Department of Geriatrics, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou…
- Department of Cardiovascular Medicine, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhuhai, Guangdong 519000, China.
- Department of Cardiology, Kiang Wu Hospital, Macau.
- Division of Cardiology, Heart and Vascular Center, Washington University in St Louis, Barnes-Jewish Hospital, St Louis 63110, MO, United States.
- Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong 519000, China. Electronic address: pancx@mail.sysu.edu.cn.
- Department of Cardiovascular Medicine, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhuhai, Guangdong 519000, China; Guangdong-Hong Kong-Macao University Joint Laboratory of Interventional Medicine, The Fifth…
Förderung
- National Natural Science Foundation of China
- Fundo para o Desenvolvimento das Ciências e da Tecnologia
Zitieren
APA
Huang, Y., Tang, W., Xu, M., Luo, L., Chong, T. K., Guan, Q., Huang, K., Liu, K., Pan, C., & Chen, J. (2025). Enhancing myocardial injury recovery: Nrf2 activation by sulforaphane regulates ferroptosis and oxidative stress in takotsubo-like models. International Immunopharmacology, 167, 115659. https://doi.org/10.1016/j.intimp.2025.115659
Vancouver
Huang Y, Tang W, Xu M, Luo L, Chong TK, Guan Q, et al. Enhancing myocardial injury recovery: Nrf2 activation by sulforaphane regulates ferroptosis and oxidative stress in takotsubo-like models. International Immunopharmacology. 2025;167:115659. doi:10.1016/j.intimp.2025.115659
BibTeX
@article{Huang2025,
author = {Huang, Yuxi and Tang, Wenyi and Xu, Mei and Luo, Liyun and Chong, Tou Kun and Guan, Qianglin and Huang, Kaizhuang and Liu, Kan and Pan, Cunxue and Chen, Jian},
title = {Enhancing myocardial injury recovery: Nrf2 activation by sulforaphane regulates ferroptosis and oxidative stress in takotsubo-like models},
journal = {International Immunopharmacology},
year = {2025},
volume = {167},
pages = {115659},
doi = {10.1016/j.intimp.2025.115659}
}
EUVIMED